AzTrials
AzTrials

Endotracheal IntubationPhase 4NCT02253979

Comparison of VivaSightTM Double Lumen Tube With a Conventional Double Lumen Tube

A Phase 4 study testing Standard double lumen tube and VivaSight double lumen tube in people with Endotracheal Intubation and Airway Management, run by Rambam Health Care Campus.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Double lumen tube (DLT) is an enotracheal tube that facilitates one lung ventilation. The DLT exact position in the airways is verified by fiber-optic bronchoscopy (FOB) after intubation. The VivaSight TM DL is a single use left DLT with a camera embedded in the tube's right side port. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
Standard double lumen tube and VivaSight double lumen tube
Type of treatment
Medical device
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
71 participants
Where
No sites listed yet
Study dates
Jan 2013to Jul 2014
Phase
Phase 4
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • adult patients undergoing video assisted thoracoscopic lung lobectomy

Who cannot join

  • anticipated difficult intubation, patients who required rapid sequence induction
  • patients with known tracheal pathology

About this study

Official title: Comparison of VivaSightTM Double Lumen Tube With a Conventional Double Lumen Tube in Adult Patients Undergoing Video Assisted Thoracoscopic Surgery

Double lumen tube (DLT) is an enotracheal tube that facilitates one lung ventilation. The DLT exact position in the airways is verified by fiber-optic bronchoscopy (FOB) after intubation. The VivaSight TM DL is a single use left DLT with a camera embedded in the tube's right side port. This study was designed to compare the VivaSightTM DL to the standard DLT.

Read the detailed description

Double lumen tube (DLT) is an enotracheal tube that facilitates one lung ventilation. The efficiency of the DLT depends on its exact position in the airways, as verified by fiber-optic bronchoscopy (FOB) after intubation, and re-verified after positioning the patient on the lateral position. The VivaSight TM DL is a single use left DLT with a camera embedded in the tube's right side port. The view from the camera appears continuously on a monitor. This study was designed to compare the VivaSightTM DL to the standard DLT. The primary end point is the time required for intubation with visual confirmation of DLT position.

Being tested
Standard double lumen tube, VivaSight double lumen tube

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Standard double lumen tubeDevice

    Endotracheal left side double lumen tube

  • VivaSight double lumen tubeDevice

    VivaSight double lumen endotracheal intubation

Study groups in NCT02253979
Study groupRoleWhat they receive
standard double lumen tubePlacebo comparatorIntervention: Standard double lumen tube
Receives: Device: Standard double lumen tube
VivaSight double lumen tubeExperimentalIntervention: VivaSight double lumen tube
Receives: Device: VivaSight double lumen tube

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Time required for endotracheal intubation with visual confirmation of double lumen tube position position.

    Measured: During induction of general anesthesia

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 Oct 2014 (estimated)
  2. Study startJan 2013
  3. Primary completionJul 2014
  4. Study completionJul 2014

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
71 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02253979
Sponsor's protocol ID
0334-12-RMB_CTIL
Status last verified
Sep 2014
First submitted
28 Sep 2014
Last updated
1 Oct 2014
Results posted
No
Data monitoring committee
Yes

Publications

  • Heir JS, Purugganan R, Jackson TA, Norman PH, Cata JP, Kosturakis A, Thakar D. A retrospective evaluation of the use of video-capable double-lumen endotracheal tubes in thoracic surgery. J Cardiothorac Vasc Anesth. 2014 Aug;28(4):870-2. doi: 10.1053/j.jvca.2013.11.011. Epub 2014 Mar 20.

    PubMed 24656617
  • Inoue S, Nishimine N, Kitaguchi K, Furuya H, Taniguchi S. Double lumen tube location predicts tube malposition and hypoxaemia during one lung ventilation. Br J Anaesth. 2004 Feb;92(2):195-201. doi: 10.1093/bja/aeh055.

    PubMed 14722168
  • Klein U, Karzai W, Bloos F, Wohlfarth M, Gottschall R, Fritz H, Gugel M, Seifert A. Role of fiberoptic bronchoscopy in conjunction with the use of double-lumen tubes for thoracic anesthesia: a prospective study. Anesthesiology. 1998 Feb;88(2):346-50. doi: 10.1097/00000542-199802000-00012.

    PubMed 9477054

Questions about this trial

What is this clinical trial studying?

A Phase 4 study testing Standard double lumen tube and VivaSight double lumen tube in people with Endotracheal Intubation and Airway Management, run by Rambam Health Care Campus.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 1 Oct 2014. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 4 studies take place after a treatment is approved, to learn more about its long-term benefits and risks in everyday use.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Time required for endotracheal intubation with visual confirmation of double lumen tube position position. (time frame: During induction of general anesthesia). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02253979, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Oct 2014.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in